Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,3.5X11.5: medical device reports filed with FDA

5,212 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

5,212
device reports naming the brand
0% of all MAUDE reports · about 745 a year
1,601
reports, 12 months to August 2026
1,205 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

5,212 medical device reports received by FDA name the brand "GM Helix Acqua Implant,Ti,3.5X11.5" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from July 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

1,601 reports arrived in the 12 months to August 2026, up 33% from 1,205 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.5%), loss of osseointegration (20.7%) and fracture (0.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0129258Sep 2021: 49Oct 2021: 46Nov 2021: 26Dec 2021: 162022Jan 2022: 43Feb 2022: 37Mar 2022: 68Apr 2022: 60May 2022: 56Jun 2022: 50Jul 2022: 30Aug 2022: 45Sep 2022: 32Oct 2022: 60Nov 2022: 81Dec 2022: 702023Jan 2023: 77Feb 2023: 49Mar 2023: 59Apr 2023: 55May 2023: 60Jun 2023: 58Jul 2023: 60Aug 2023: 62Sep 2023: 63Oct 2023: 84Nov 2023: 50Dec 2023: 642024Jan 2024: 60Feb 2024: 59Mar 2024: 56Apr 2024: 74May 2024: 86Jun 2024: 73Jul 2024: 99Aug 2024: 92Sep 2024: 101Oct 2024: 85Nov 2024: 104Dec 2024: 1152025Jan 2025: 75Feb 2025: 97Mar 2025: 89Apr 2025: 60May 2025: 0Jun 2025: 258Jul 2025: 124Aug 2025: 97Sep 2025: 87Oct 2025: 152Nov 2025: 121Dec 2025: 1272026Jan 2026: 125Feb 2026: 104Mar 2026: 144Apr 2026: 140May 2026: 125Jun 2026: 182Jul 2026: 117Aug 2026: 177

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

06441,2872019: 2020192020: 12420202021: 29020212022: 63220222023: 74120232024: 1,00420242025: 1,28720252026: 1,1142026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,212
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report78.6%4,096
Voluntary report0%0
User facility report0%0
Distributor report21.4%1,116
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,83273.5%62.8%
Loss of osseointegration1,08120.7%22.4%
Fracturea broken bone480.9%1.6%
Difficult to insertthe device was hard to insert300.6%0.4%
Separation failure110.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,54129.6%
Painpain, site not specified1,28024.6%
Inflammationinflammation4127.9%
Hemorrhage/blood loss/bleeding3116%
Swelling/ edema2474.7%
Fistula1663.2%
Abscessa collection of pus1613.1%
Hyperresponsive to stimuli1402.7%
Hypersensitivity/allergic reaction661.3%
Tissue damage591.1%
Numbnessnumbness220.4%
Sinus perforation150.3%
Failure of implant140.3%
Swellingswelling60.1%
Inadequate osseointegration30.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,3.5X11.5Product code DZEAll MAUDE reports
Reports5,2123,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer78.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,3.5X11.5 reports

How many FDA reports name GM Helix Acqua Implant,Ti,3.5X11.5?

5,212 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,601 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.5%), loss of osseointegration (20.7%), fracture (0.9%), difficult to insert (0.6%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (78.6%) and distributor reports (21.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,3.5X11.5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.